SARS-CoV-2 and Rhinovirus/Enterovirus co-infection in a critically ill young adult patient in Colombia: A case report

Biomédica

View Publication Info
 
 
Field Value
 
Title SARS-CoV-2 and Rhinovirus/Enterovirus co-infection in a critically ill young adult patient in Colombia: A case report
Co-infección por SARS-CoV-2 y Rinovirus/Enterovirus en paciente adulta joven críticamente enferma en Colombia: Un reporte de caso
 
Creator Orozco-Hernández , Juan Pablo
Montoya-Martínez, Juan José
Pacheco-Gallego, Manuel Conrado
Céspedes-Roncancio , Mauricio
Porras-Hurtado, Gloria Liliana
 
Subject Coronavirus infections
pneumonia
; respiratory distress syndrome, adult
case reports
Rhinovirus
Colombia
infecciones por coronavirus
neumonía
síndrome de dificultad respiratoria del adulto
informes de casos
Rhinovirus
Colombia
 
Description The current SARS-CoV-2 pandemic has caused a huge global public health problem. The case of a young adult patient with laboratory confirmed SARS-CoV-2 is reported, which describes the identification, clinical course, diagnosis, treatment, including her rapid clinical deterioration with mild initial symptoms and subsequent progression to multilobar pneumonia requiring admission to the intensive care unit. This case highlights the importance of establishing a diagnosis based on the clinical findings and the patient's history, bearing in mind the possibility of gastrointestinal symptoms in addition to respiratory ones. Besides, the presence of risk factors should be investigated; in this case we proposed obesity as a possible risk factor. Furthermore, limitations in diagnostic tests and the possibility of co-infection with other respiratory pathogens are highlighted. The imaging, laboratory findings and treatment are described, taking into account the limited current evidence.
La actual pandemia por SARS-CoV-2 ha ocasionado un enorme problema de salud pública mundial. Se reporta el caso de una paciente joven adulta con SARS-CoV-2 confirmado por laboratorio en el cual se describe la identificación, curso clínico, diagnóstico, tratamiento, incluyendo el rápido deterioro clínico que tuvo con síntomas leves iniciales y posterior progresión a una neumonía multilobar requiriendo ingreso a la unidad de cuidado intensivo. Este caso destaca la importancia de establecer un diagnostico basado en la clínica y los antecedentes del paciente, teniendo presente la posibilidad de síntomas gastrointestinales en adición a los respiratorios. Además, se debe indagar la presencia de factores de riesgo, siendo en este caso, la obesidad un posible factor influyente. Asimismo, se resaltan las limitaciones en las pruebas diagnósticas, la posibilidad de co-infección con otros patógenos respiratorios y se describen los hallazgos de imágenes, de laboratorio y el tratamiento teniendo presente la escasa evidencia actual.
 
Publisher Instituto Nacional de Salud
 
Date 2020-05-07
 
Type info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
 
Format application/pdf
 
Identifier https://revistabiomedica.org/index.php/biomedica/article/view/5516
10.7705/biomedica.5516
 
Source Biomedica; Vol. 40 No. Supl. 2 (2020): Infecciones respiratorias
Biomédica; Vol. 40 Núm. Supl. 2 (2020): Infecciones respiratorias
2590-7379
0120-4157
 
Language spa
 
Relation https://revistabiomedica.org/index.php/biomedica/article/view/5516/4565
/*ref*/Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708‐20. https://doi.org/10.1056/NEJMoa2002032 2. Ministerio de Salud y Protección Social. Nuevo Coronavirus COVID-19. Fecha de consulta: 23 de abril del 2020. Disponible en: https://www.minsalud.gov.co/portada-covid-19.html 3. Livingston E, Bucher K. Coronavirus disease 2019 (COVID-19) in Italy. JAMA. 2020;323:1335. https://doi.org/10.1001/jama.2020.4344 4. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054-62. https://doi.org/10.1016/S0140-6736(20)30566-3 5. Fauci AS, Lane HC, Redfield RR. Covid-19 — Navigating the Uncharted. N Engl J Med. 2020;382:1268-9. https://doi.org/10.1056/NEJMe2002387 6. Young BE, Ong SWX, Kalimuddin S, Low JG, Tan SY, Loh J, et al. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA. 2020;323:1488-94. https://doi.org/10.1001/jama.2020.3204 7. Fineberg HV. Ten Weeks to Crush the Curve. N Engl J Med. 2020 382:e37. https://doi.org/10.1056/NEJMe2007263 8. Tian Y, Rong L, Nian W, He Y. Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission. Aliment Pharmacol Ther. 2020;51:843‐51. https://doi.org/10.1111/apt.15731 9. Gane SB, Kelly C, Hopkins C. Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome? Rhinology. 2020;58:289-94. https://doi.org/10.4193/Rhin20.114 10. Gu J, Han B, Wang J. COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission. Gastroenterology. 2020;158:1518‐19. https://doi.org/10.1053/j.gastro.2020.02.054 11. Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020;382:929-36. https://doi.org/10.1056/NEJMoa2001191 12. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033-4. https://doi.org/10.1016/S0140-6736(20)30628-0 13. Tan L, Wang Q, Zhang D, Ding J, Huang Q, Tang Y-Q, et al. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduct Target Ther. 2020;5:33. https://doi.org/10.1038/s41392-020-0148-4 14. Lippi G, Wong J, Henry BM. Hypertension and its severity or mortality in Coronavirus Disease 2019 (COVID-19): a pooled analysis. Pol Arch Intern Med. 2020;130:304-9. https://doi.org/10.20452/pamw.15272 15. Ellulu MS, Patimah I, Khaza'ai H, Rahmat A, Abed Y. Obesity and inflammation: the linking mechanism and the complications. Arch Med Sci. 2017;13:851-63. https://doi.org/10.5114/aoms.2016.58928 16. Lippi G, Simundic AM, Plebani M. Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19). Clin Chem Lab Med. 2020:20200285. https://doi.org/10.1515/cclm-2020-0285 17. Xiao AT, Tong YX, Zhang S. False-negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: Rather than recurrence. J Med Virol. 2020. https://doi.org/10.1002/jmv.25855 18. Kim D, Quinn J, Pinsky B, Shah NH, Brown I. Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens. JAMA. 2020;e206266. https://doi.org/10.1001/jama.2020.6266 19. Ding Q, Lu P, Fan Y, Xia Y, Liu M. The clinical characteristics of pneumonia patients co-infected with 2019 novel coronavirus and influenza virus in Wuhan, China. J Med Virol. 2020;1-7. https://doi.org/10.1002/jmv.25781 20. Khodamoradi Z, Moghadami M, Lotfi M. Co-infection of coronavirus disease 2019 and influenza A: A report from Iran. Arch Iran Med. 2020;23:239-43. https://doi.org/10.34172/aim.2020.04 21. Prompetchara E, Ketloy C, Palaga T. Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol. 2020;38:1-9. https://doi.org/10.12932/AP-200220-0772 22. Dong L, Hu S, Gao J. Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discov Ther. 2020;14:58-60. https://doi.org/10.5582/ddt.2020.01012 23. Cortegiani A, Ingoglia G, Ippolito M, Giarratano A, Einav S. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. J Crit Care. 2020. https://doi.org/10.1016/j.jcrc.2020.03.005 24. Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020. https://doi.org/10.1016/j.ijantimicag.2020.105949 25. Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Sevestre J, et al. Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study. Travel Med Infect Dis. 2020. https://doi.org/10.1016/j.tmaid.2020.101663 26. Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020;382:1787‐99. https://doi.org/10.1056/NEJMoa2001282 27. Alhazzani W, Møller MH, Arabi YM, Loeb M, Gong MN, Fan E, et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med. 2020. https://doi.org/10.1007/s00134-020-06022-5 28. Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the cns: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci. 2020;11:995-8. https://doi.org/10.1021/acschemneuro.0c00122 29. Humberto C, Trujillo S, Gutiérrez A, Rodriguez-Morales A, Javier A, Mejía N, et al. Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-COV-2/COVID-19 en establecimientos de atención de la salud - Recomendaciones basadas en consenso de expertos e informadas en la evidencia. Infectio. 2020;24:1-102. https://doi.org/10.22354/in.v24i3.851
 

Contact Us

The PKP Index is an initiative of the Public Knowledge Project.

For PKP Publishing Services please use the PKP|PS contact form.

For support with PKP software we encourage users to consult our wiki for documentation and search our support forums.

For any other correspondence feel free to contact us using the PKP contact form.

Find Us

Twitter

Copyright © 2015-2018 Simon Fraser University Library